REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medi Pharma Sp. z o.o. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmaceutical Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Supermarkets and Other Grocery (except Convenience) Stores | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Other Miscellaneous Store Retailers | Warehousing and Storage | Lessors of Real Estate
Full name: Medi Pharma Sp. z o.o. Profile Updated: May 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Medi Pharma Sp. z o.o. is a company in Poland, with a head office in Lublin. It operates in the Department Stores industry. Medi Pharma Sp. z o.o. was incorporated on May 18, 2017. The latest financial highlights indicate a net sales revenue drop of 42.12% in 2022. Its total assets grew by 7.68% over the same period. In, 2022, the company’s net profit margin increased by 18.06%.

Headquarters
Ul. Boleslawa Chrobrego 6
Lublin; Lubelskie; Postal Code: 20-611

Contact Details: Purchase the Medi Pharma Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Medi Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Medi Pharma Sp. z o.o. report to view the information.
Incorporation Date:
May 18, 2017
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Medi Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-42.12%▼
Total operating revenue
-25.2%▼
Operating profit (EBIT)
589.13%▲
Net Profit (Loss) for the Period
574.54%▲
Total assets
7.68%▲
Total equity
N/A
Operating Profit Margin (ROS)
20.09%▲
Net Profit Margin
18.06%▲
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo